This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
|Zacks Rank||Definition||Annualized Return|
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
Many emerging markets have had a rough 2013. Outflows from developing nations have been a serious problem as weak currencies and a desire for more U.S. exposure have led to huge losses.
While the focus of this selling pressure has largely been on big Asian markets like India or Indonesia, Latin America hasn’t been immune either. This region has also struggled over the past six months, as commodity prices have been somewhat sluggish overall, and a risk-off trade in these nations hasn’t helped matters.
Although Brazil usually leads the way in this regard, investors should be aware of Colombia too. The nation had been a star performer for quite a while, but it has fallen on hard times lately. Plus, a program by the central bank to weaken the peso—which arguably helps exporters—doesn’t exactly have a positive impact for U.S. investors in the meantime.
Thanks to these factors, the once-star performer of Bancolombia (CIB - Free Report) is probably a stock that you want to avoid for the time being.
Bancolombia in Focus
Bancolombia is the largest commercial bank in Colombia, offering a full range of financial products. The firm is based in Medellin and it has nearly 1,000 offices, though its network stretches to other Latin American countries, and the U.S. and Spain as well.
CIB surged in the aftermath of the financial crisis as demand for emerging markets were strong, as prices moved from under $20 a share in 2009, to over $60 in mid-2010. Lately however, prices hit just above the $70/share mark and have had trouble maintaining that lofty level ever since. In fact, CIB’s shares have declined by 15.6% YTD, including an 8.7% slump in the past six months.
Factors for the slump
In addition to the macro issues, the estimates picture for CIB has been quite unfavorable as well. The company has seen the consensus estimate slump over the past two months, plunging from $4.66/share to its current level around $3.99/share.
Growth levels are also quite poor for the company, with a -10.66% earnings contraction expected for the full year. If that wasn’t enough, growth over the next five year is expected to come in below the industry average, and in the high single digit percentage range.
While such a level might be tolerable in a developed country, CIB is in an emerging market with a growing population, so it is questionable why the growth is so low for this company. And CIB is also looking quite poor for this earnings season too; the company just had a horrendous miss in their most recent report, while the Zacks Earnings ESP comes in negative, suggesting that another miss may be around the corner for this Colombian bank.
Thanks to these factors, CIB has earned itself a Zacks Rank #5 (Strong Sell), meaning that it is likely to underperform in the weeks ahead. And with a Zacks Recommendation of underperform, the longer term picture isn’t looking much better.
While the foreign bank industry might not have that great of a Zacks Industry Rank—bottom 50%-- there are a couple top ranked companies that may be better picks than CIB. These include (BBVA - Free Report) , (GGAL - Free Report) , and (SMFG - Free Report) .
All three of these companies have a top Zacks Rank #1, and thus may be better choices in the foreign banking world. Best of all, the trio has seen their ranks surge in the past week to the #1 level, suggesting that now is the perfect time to focus on these instead of the likely-to-underperform CIB.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>